Ochre Bio
RNA medicines for liver diseases
Ochre Bio is a company in vc portfolio based in Oxford, England, United Kingdom, founded in 2019.
Profile
Ochre Bio is a biotechnology company developing RNA therapies for chronic liver diseases. Using a combination of genomic deep phenotyping, precision RNA medicine, and testing in live human donor livers, Ochre is developing therapies for important liver health challenges, from increasing donor liver supply to reducing cirrhosis complications.
As a business in vc portfolio, Ochre Bio is listed here with the public details available about it.
The business is associated with Oxford, England, United Kingdom.
Directory data places it at the Winter 2020 stage.
Recorded headcount: 50 employees.
| Sector | VC Portfolio |
|---|---|
| Headquarters | Oxford, England, United Kingdom |
| Country | United Kingdom |
| Founded | 2019 |
| Employees | 50 |
| Stage | Winter 2020 |
Website: www.ochre-bio.com
Sign in to view the contact information we hold for Ochre Bio.
Create a free account
Create a free account